17695487

Source:http://linkedlifedata.com/resource/pubmed/id/17695487

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:17695487	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:17695487	lifeskim:mentions	umls-concept:C0013216	lld:lifeskim
pubmed-article:17695487	lifeskim:mentions	umls-concept:C0205969	lld:lifeskim
pubmed-article:17695487	lifeskim:mentions	umls-concept:C0206135	lld:lifeskim
pubmed-article:17695487	lifeskim:mentions	umls-concept:C0936012	lld:lifeskim
pubmed-article:17695487	lifeskim:mentions	umls-concept:C0868928	lld:lifeskim
pubmed-article:17695487	lifeskim:mentions	umls-concept:C0205453	lld:lifeskim
pubmed-article:17695487	lifeskim:mentions	umls-concept:C0205179	lld:lifeskim
pubmed-article:17695487	lifeskim:mentions	umls-concept:C0701185	lld:lifeskim
pubmed-article:17695487	pubmed:issue	4C	lld:pubmed
pubmed-article:17695487	pubmed:dateCreated	2007-8-15	lld:pubmed
pubmed-article:17695487	pubmed:abstractText	Optimal chemotherapeutic regimen in thymic carcinoma remains uncertain and the efficacy of second line chemotherapy has not been established either.	lld:pubmed
pubmed-article:17695487	pubmed:language	eng	lld:pubmed
pubmed-article:17695487	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17695487	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:17695487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17695487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17695487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17695487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17695487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17695487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17695487	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17695487	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:17695487	pubmed:issn	0250-7005	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:KoizumiTomono...	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:KuboKeishiK	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:TsushimaKenji...	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:YasuoMasanori...	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:TakamizawaAke...	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:UrushihataKaz...	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:SasabayashiMa...	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:YoshikawaSumi...	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:KandaShintaro...	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:OkadaMitsuyoM	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:HatayamaOrieO	lld:pubmed
pubmed-article:17695487	pubmed:author	pubmed-author:KomatsuYoshim...	lld:pubmed
pubmed-article:17695487	pubmed:issnType	Print	lld:pubmed
pubmed-article:17695487	pubmed:volume	27	lld:pubmed
pubmed-article:17695487	pubmed:owner	NLM	lld:pubmed
pubmed-article:17695487	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:17695487	pubmed:pagination	3005-8	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:meshHeading	pubmed-meshheading:17695487...	lld:pubmed
pubmed-article:17695487	pubmed:articleTitle	Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases.	lld:pubmed
pubmed-article:17695487	pubmed:affiliation	First Department of Internal Medicine, Shinshu University School of Medicine, 3-1-1, Asahi Matsumoto, Japan.	lld:pubmed
pubmed-article:17695487	pubmed:publicationType	Journal Article	lld:pubmed